A lab-made copy of a protein found in your stomach, studied for helping the body heal injured tissue.
Tendon, ligament, muscle, and gut-lining repair.
Nearly all the evidence is in animals — there are no completed human trials, and the FDA restricted it from compounding in 2022.
What it is
BPC-157 is a lab-made version of a protein fragment found in the stomach's protective lining. It doesn't exist in this exact form in your body naturally — researchers isolated a sequence from gastric proteins to study whether the gut's remarkable ability to heal itself could be applied elsewhere. It promotes new blood vessel formation, activates repair cells called fibroblasts, and influences nitric oxide signaling, which affects blood flow and inflammation. The animal research has been going on since the 1990s, primarily from one Croatian research group, and the results for gut healing and soft tissue repair are consistently compelling. What's absent is the human trial data. There are no completed randomized controlled trials in people. The FDA restricted it from compounding pharmacies in 2022 because of insufficient human data — which is the regulatory way of saying the animal evidence, however interesting, hasn't been confirmed in humans yet.
Potential benefits
Tissue & Tendon Repair
Animal studies show accelerated healing of tendons, ligaments, and muscle. Activates repair pathways in fibroblasts.
GI Tract Protection
Strongest animal evidence. Protects stomach lining, reduces colitis-related inflammation. Biologically consistent with its gastric origin.
Anti-Inflammatory
Reduces TNF-alpha and IL-6 in animal models. Human mechanism not confirmed.
Nervous System / Mood
Early animal data suggests dopamine/serotonin pathway interaction. Not a basis for treating mental health conditions.
Risks and contraindications
Side Effects
- Dizziness, lightheadedness (vasodilatory effects)
- Local injection site irritation
- Nausea, appetite changes
- Compound quality risk — unregulated sourcing
Theoretical Risks
- Angiogenesis may theoretically feed cancer cells
- Hormonal interaction via GH receptor upregulation
- Immune modulation with chronic use
Contraindications / cautions
- Active or history of cancer (angiogenesis risk)
- Pregnancy / breastfeeding
- Under 18 · Autoimmune conditions (caution)
- Anticoagulants or blood pressure medications (caution)
Research reality
Hundreds of studies since the 1990s have documented healing, GI protection, and anti-inflammatory effects. Most of this work comes from one Croatian research group, and independent replication by other labs has been limited — which is worth knowing when weighing the strength of the evidence.
No completed randomized controlled trials in humans exist. The available human information comes from small case reports only. We genuinely cannot confirm how it works, how well it works, or whether it's safe in humans based on current data.
Long-term human safety data does not exist. The effects of ongoing use are entirely unknown. The absence of reported harm isn't the same as confirmed safety — it largely reflects the absence of formal study. The FDA's 2022 restriction from compounding was based specifically on this evidence gap.
Promising preclinical story. The absence of long-term human data is a real unknown — not a technicality. Cancer risk factors are the most important screening question given the angiogenesis mechanism. We'll walk through the trade-offs with you before any decision.